About this episode
This episode takes you on an in-depth journey into PE-22-28, a fascinating neuroactive peptide gaining attention in research for its potential effects on mood, memory, and stress resilience. You’ll learn how it works in the brain, why scientists are exploring it for anxiety, depression, and cognitive health, and how it compares to other well-known peptides like Semax and Selank. We’ll cover its mechanisms, possible delivery methods, what animal studies reveal, and the big questions still unanswered in human trials. Whether you’re curious about nootropics, brain health, or the future of peptide science, this episode offers a balanced and thought-provoking exploration of what PE-22-28 might mean for mental well-being and neuroprotection.
Get every episode summarized
Each time The Peptide Effect publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Peptide Effect
The Hidden GLP-1 Switch: How These Drugs May Reprogram Pancreatic Cells
The Peptide Effect
The Science of Peptide-Based Myostatin Inhibitors: Can We Unlock More Muscle?
The Peptide Effect
Apolipoprotein-Targeting Peptides: The Future of Cholesterol, Brain Health, and...
The Peptide Effect
Border Seizures and the Peptide Market: What’s Happening to Supply, Pricing, and...
The Peptide Effect